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Summary
Aging is a major risk factor for chronic disease in the human
population, but there are little human data on gene expression
alterations that accompany the process. We examined human
peripheral blood leukocyte in-vivo RNA in a large-scale transcrip-
tomic microarray study (subjects aged 30–104 years). We tested
associations between probe expression intensity and advancing
age (adjusting for confounding factors), initially in a discovery set
(n = 458), following-up findings in a replication set (n = 240). We
confirmed expression of key results by real-time PCR. Of 16 571
expressed probes, only 295 (2%) were robustly associated with
age. Just six probes were required for a highly efficient model for
distinguishing between young and old (area under the curve in
replication set; 95%). The focused nature of age-related gene
expression may therefore provide potential biomarkers of aging.
Similarly, only 7 of 1065 biological or metabolic pathways were
age-associated, in gene set enrichment analysis, notably including
the processing of messenger RNAs (mRNAs); [P < 0.002, false
discovery rate (FDR) q < 0.05]. This is supported by our
observation of age-associated disruption to the balance of alter-
natively expressed isoforms for selected genes, suggesting that
modification of mRNA processing may be a feature of human
aging.
Key words: aging; cell senescence; mRNA processing; gene
expression; predictive model.
Introduction
Advancing age is a major risk factor for many common diseases, including
type 2 diabetes, cardiovascular disease, and many cancers (Butler et al.,
2008). However, aging is characterized by progressively rising heteroge-
neity, with some people becoming frail in their 70s while others remain fit
into their 90s or even longer. Characterizing the changes underpinning
the heterogeneity of aging processes at a molecular level has been a
long-held goal.
One theory of aging is that random and widespread unrepaired dam-
age to DNA (and other molecules) accumulated over a lifetime may cause
cellular senescence (Gensler et al., 1981), but it has not been established
whether such damage is associated with large-scale alterations of gene
expression in the aged human population. Alteration to highly sequence-
dependent processes such as mRNA processing (Cartegni et al., 2002)
has been suggested in previous studies (Yannarell et al., 1977; Meshorer
& Soreq, 2002), but to date, there are little human data to assess this
empirically. Several age-related diseases are known to be caused by alter-
ations in the splicing patterns of the mRNA transcripts, including the
Hutchison Gilford progeria syndrome, where premature aging is caused
by a synonymous mutation (G608G) in the Lamin A (LMNA) gene, which
obstructs the normal post-translational processing of the protein product
and leads to the premature aging phenotype (Eriksson et al., 2003). Simi-
larly, alterations in the relative balance of alternatively expressed microtu-
bule-associated protein tau (MTAP) isoforms are a feature of Alzheimer’s
disease-related tauopathies. (Chen et al., 2010).
Gene expression arrays provide a powerful technology for identifying
age-related alteration to the levels of gene transcripts in a comprehensive
genome-wide way. Identification of individual transcripts and functionally
coherent gene sets that are under- or over-expressed with aging in
humans would provide key insights into the mechanisms of aging pro-
cesses and age-related disease (Zahn et al., 2006). This may provide a
‘biomarker signature’ for monitoring the effects of interventions to slow
age-related changes, in an easily accessible tissue, peripheral blood
leukocytes.
A variety of age-related expression analyses in cell lines or stored cell
material have been reported, although results have had limited reproduc-
ibility (de Magalhaes et al., 2009). This is likely to be due to the small sam-
ple sizes in previous studies and to the sensitivity of mRNA transcripts to
variation in aspects of storage and handling (Min et al., 2010). It is clear
that identifying robust changes in age-related gene expression in humans
will depend on large numbers of samples collected with optimal sample
handling, so that results reflect in-vivo mRNA expression. Blood-derived
leukocytes are a relevant tissue for the study of in-vivo aging processes in
humans, as ‘immunosenescence’ is well described (Gruver et al., 2007).
Blood is likely to remain the principal accessible ‘live’ tissue for large-scale
in-vivo expression studies and clinical analysis in humans. Blood-derived
white cell transcriptome studies have already proved valuable in identify-
ing signatures of major diseases and drug responses some with promising
clinical applications (Dumeaux et al., 2010).
We used a well-characterized population representative cohort, the
InCHIANTI aging study (Ferrucci et al., 2000), to examine transcriptome-
wide alterations in gene expression associated with chronological age in
samples from 698 individuals by microarray analysis. We predicted
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widespread transcriptomic alterations with advancing age, and that
inflammatory or immune function genes would be prominent in our
results given our choice of target tissue (peripheral white blood cells).
We aimed to identify both the most deregulated individual transcripts,
but also the most deregulated gene sets grouped into biological path-
ways.
We found that although the largest single-transcript associations in
human peripheral blood leukocytes do indeed include genes involved in
inflammation or immune function, widespread alterations in gene expres-
sion levels were not apparent. In fact, only a very small proportion (295 of
16 571 transcripts; 2%) of transcripts demonstrated robust age-related
differences in gene expression. Furthermore, a statistical model using just
6 of the top 25 transcripts was able to classify samples into ‘young’ or
‘old’ with high precision. These six transcripts may provide a biomarker
set to monitor interventions aimed at slowing aging. Gene set enrichment
analysis (GSEA) (a method to determine whether specific molecular or
functional pathways are associated with a given trait) demonstrated that
the pathways most disrupted by human aging include genes involved in
messenger RNA splicing, polyadenylation, and other post-transcriptional
events. This was accompanied by specific changes in the ratios of expres-
sion between isoform-specific transcripts for selected genes in our
extended analysis. Deregulation of mRNA processing pathways may com-
prise a mechanism involved in human cellular aging.
Results
A small proportion of transcripts demonstrate marked age-
related expression differences
A total of 16 571 transcripts gave reliable signals above background
(P £ 0.01) in > 5% of the sample population following QC of microarray
data and were selected for analysis of gene expression alterations with
age. The cohort was divided into discovery and test sets, based on analyti-
cal batch. Individual probes were only considered to be associated with
chronological age (with adjustment for major confounders) if they
reached a false discovery rate (FDR) q < 0.001 in the discovery set and
also replicated in the test set with an FDR q < 0.05. Of 16 571 transcripts,
we identified gene expression differences with age in only 2%; 360
probes in the discovery set, of which 295 replicated in our test set (see
Table S1). Fifty (18%) of differentially expressed transcripts were up-reg-
ulated and 245 were down-regulated. Analysis of the extremes of the
age distribution only (< 50 years (n = 93) vs. > 80 years (n = 232)
yielded only 53 probes associated with age, supporting our observation
that human aging is associated with large-scale alterations in the expres-
sion of only a small number of transcripts.
The chemokine receptor 6 (CCR6), chemokine receptor 7 (CCR7), and
CD27 genes, previously associated with age and immunosenescence
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Fig. 1 The expression of key genes with age. The figure
shows the association between probe signal intensity
(arbitrary units; Y-axis) and age (years; X-axis) for three genes
known to be associated with age; CD27, chemokine receptor
6, and CCR7 (a–c), the top three down-regulated genes in our
study; leucine-rich repeat neuronal protein 3, CD248, and
lymphoid enhancer-binding factor 1 (d–f) and the top three
up-regulated genes in our study; vesicle-associated membrane
protein 5, GBP1, and signal transducer and activator of
transcription 1 (g–i).
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(Yung et al., 2007), were also found to be associated with age in our
study. Plots of microarray signal intensity against increasing age (Cloud
plots) for these, and the top 3 up- and down-regulated genes in our anal-
ysis, namely leucine-rich repeat neuronal protein 3 (LRRN3), endosialin
(CD248), lymphoid enhancer-binding factor 1 (LEF1), vesicle-associated
membrane protein 5 (VAMP5), guanylate binding protein 5 (GBP5), and
signal transducer and activator of transcription 1 (STAT1), are presented
in Fig. 1. The 25 most up-regulated and the 25 most down-regulated
transcripts are shown in Table 1. The most statistically significant associa-
tion between age and gene expression was for the LRRN3 gene
Table 1 The most strongly (a) down-regulated (b) up-regulated genes with advancing age, by discovery and replication set
Number
(by discovery
P-value) Probe Probe ID
Discovery set Replication set
Age coefficient P-value FDR q-value Age coefficient P-value FDR q-value
1 LRRN3 ilmn_1773650 )0.0058 9.20E-32 8.20E-28 )0.0067 3.70E-16 2.20E-12
2 CD248 ilmn_1726589 )0.003 3.40E-27 1.50E-23 )0.0032 1.20E-17 1.40E-13
3 LRRN3 ilmn_2048591 )0.0029 1.80E-23 5.40E-20 )0.0023 1.30E-06 5.00E-04
4 LEF1 ilmn_2213136 )0.0124 4.20E-16 9.30E-13 )0.0131 7.60E-09 1.20E-05
5 LEF1 ilmn_1679185 )0.0131 2.80E-15 5.00E-12 )0.0146 4.20E-09 8.70E-06
6 NELL2 ilmn_1725417 )0.0055 8.80E-15 1.30E-11 )0.0056 2.70E-08 3.10E-05
7 ABLIM1 ilmn_1785424 )0.0092 2.00E-14 2.50E-11 )0.0089 5.90E-07 3.00E-04
8 FAM102A ilmn_2401779 )0.0055 3.20E-14 3.60E-11 )0.006 9.00E-09 1.30E-05
9 CCR6 ilmn_1690907 )0.0024 2.40E-13 2.30E-10 )0.0022 1.10E-05 2.30E-03
10 ZSCAN18 ilmn_1654946 )0.004 7.10E-13 5.80E-10 )0.0043 7.70E-08 6.70E-05
11 BZW2 ilmn_1676548 )0.0016 7.80E-13 6.20E-10 )0.001 2.30E-03 5.68E-02
12 CCR7 ilmn_1715131 )0.0164 1.20E-12 8.10E-10 )0.0228 5.80E-10 1.70E-06
13 LTB ilmn_2376204 )0.0076 1.20E-12 8.40E-10 )0.0084 2.10E-08 2.70E-05
14 GRAP ilmn_2264011 )0.0091 1.60E-12 1.00E-09 )0.0099 4.90E-07 3.00E-04
15 HGFL ilmn_1719986 )0.011 2.10E-11 1.10E-08 )0.0127 1.70E-06 6.00E-04
16 PASK ilmn_1667022 )0.0041 2.90E-11 1.50E-08 )0.0055 5.30E-07 3.00E-04
17 KIAA1147 ilmn_2355033 )0.0044 3.10E-11 1.60E-08 )0.005 2.10E-05 3.50E-03
19 ABLIM1 ilmn_2396672 )0.0027 4.30E-11 2.00E-08 )0.0034 1.70E-06 6.00E-04
20 SYPL1 ilmn_2377174 )0.0038 6.00E-11 2.60E-08 )0.0041 8.20E-05 8.10E-03
21 CD27 ilmn_1688959 )0.0035 7.20E-11 2.90E-08 )0.0034 1.40E-06 6.00E-04
22 DQ894085 ilmn_1680618 )0.0048 7.40E-11 3.00E-08 )0.0059 1.10E-07 8.40E-05
23 DKC1 ilmn_1671257 )0.0033 1.60E-10 5.80E-08 )0.0028 2.00E-04 1.47E-02
24 FAIM3 ilmn_1775542 )0.0123 1.60E-10 5.90E-08 )0.0126 2.60E-05 4.00E-03
25 CDR2 ilmn_1720270 )0.0022 2.40E-10 8.60E-08 )0.0029 7.40E-08 6.60E-05
26 ATM ilmn_2370825 )0.0063 3.50E-10 1.20E-07 )0.0063 3.60E-03 7.25E-02
18 VAMP5 ilmn_1809467 0.0092 3.70E-11 1.80E-08 0.0073 7.60E-05 7.60E-03
42 GBP5 ilmn_2114568 0.0107 4.60E-09 9.50E-07 0.0072 1.11E-02 1.21E-01
48 STAT1 ilmn_1691364 0.012 8.60E-09 1.60E-06 0.0133 2.80E-05 4.10E-03
51 WARS ilmn_1727271 0.009 1.50E-08 2.40E-06 0.0088 2.00E-04 1.41E-02
58 WARS ilmn_2337655 0.0093 2.10E-08 3.30E-06 0.009 5.00E-04 2.41E-02
74 MT2A ilmn_1686664 0.0131 6.30E-08 7.50E-06 0.014 7.00E-05 7.20E-03
77 CTSA ilmn_1719286 0.0049 8.40E-08 9.40E-06 0.0057 2.00E-04 1.46E-02
82 SLC27A3 ilmn_1719627 0.0034 9.60E-08 1.00E-05 0.0026 4.80E-03 8.42E-02
84 FBXO6 ilmn_1701455 0.0037 1.20E-07 1.20E-05 0.0024 3.45E-02 2.00E-01
95 VCAN ilmn_1687301 0.0079 1.60E-07 1.50E-05 0.0065 3.30E-03 6.93E-02
100 EIF4G3 ilmn_1775692 0.0017 2.10E-07 1.90E-05 0.0016 2.60E-03 6.08E-02
101 DUSP3 ilmn_1797522 0.0046 2.30E-07 2.00E-05 0.0045 2.80E-03 6.30E-02
114 GZMH ilmn_1731233 0.017 5.70E-07 4.30E-05 0.0216 8.10E-06 1.90E-03
123 PSMB9 ilmn_2376108 0.0082 8.90E-07 6.00E-05 0.0061 1.18E-02 1.25E-01
133 TTC38 ilmn_2059886 0.0029 1.20E-06 7.30E-05 0.0041 7.10E-05 7.30E-03
148 SYT11 ilmn_1717934 0.0046 2.10E-06 1.00E-04 0.0049 1.90E-03 5.08E-02
142 FCGR1A ilmn_2261600 0.0095 1.70E-06 1.00E-04 0.0075 1.01E-02 1.16E-01
157 WIPI1 ilmn_1781386 0.0014 2.90E-06 2.00E-04 0.0013 3.70E-03 7.31E-02
164 P2RX7 ilmn_1759326 0.0017 3.20E-06 2.00E-04 0.0022 1.00E-03 3.80E-02
184 TTC38 ilmn_1692464 0.0042 5.20E-06 2.00E-04 0.0066 2.00E-04 1.27E-02
192 H3F3A ilmn_2402930 0.0047 6.00E-06 2.00E-04 0.0034 3.42E-02 1.99E-01
171 STOM ilmn_1766657 0.0052 4.00E-06 2.00E-04 0.0054 1.90E-03 5.13E-02
176 STAT1 ilmn_1690105 0.0063 4.30E-06 2.00E-04 0.0073 2.00E-04 1.51E-02
182 MT1A ilmn_1691156 0.0077 4.80E-06 2.00E-04 0.0092 1.00E-03 3.71E-02
205 B3GAT1 ilmn_1761093 0.0012 8.80E-06 3.00E-04 0.0018 2.90E-06 9.00E-04
The gene and probe identities are given in each case. The age coefficient, the significance P-value, and the false discovery rate (FDR) q-value are also given.
ABLIM1, actin-binding LIM protein 1; CCR6, chemokine receptor 6; LEF1, lymphoid enhancer-binding factor 1; LRRN3, leucine-rich repeat neuronal protein 3; STAT1,
signal transducer and activator of transcription 1; VAMP5, vesicle-associated membrane protein 5.
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(P = 8.2 · 10)28), thought to be involved in MAPK activity and
endocytosis.
It is possible that some of the effects we note may result from increases
in age-related variation in inter-individual expression levels. However, the
Breusch Pagan test of conditional heteroscedasticity did not provide evi-
dence to support this hypothesis. The lowest P-value for the effect of age
on residual expression variability failed to reach genome-wide signifi-
cance before or after adjustment for age effects on mean expression
(minimum P = 3.2 · 10)5, FDR q = 0.18). Therefore, these results pro-
vide no evidence for increased variability in inter-individual gene expres-
sion with age.
Six of the most deregulated 25 probes provide good
discrimination between young and old
We then identified which of the 25 most strongly age-associated probes
provide the best discrimination between a younger group (age < 65;
n = 107 in discovery set) and older subjects (age ‡ 75; n = 308 in discov-
ery set). We used multivariable logistic regression modeling to select
probes that add significantly to classification (see methods, statistical
analysis). Our final model included six genes; LRRN3, CD248, CCR6, GRAP
(growth factor receptor-bound protein 2 related adaptor protein),
VAMP5, and CD27, which together explained 63% of the age-group
associated variation (Table S2). The multivariable logistic regression
model was used to generate an age-group classification for subjects in
the independent replication set. The ROC (Receiver Operating Character-
istic) curve (Fig. S1) shows that this small subset of genes is sufficient to
achieve exceptionally strong separation between older and younger sub-
jects (ROC area under the curve, (AUC) = 96% in discovery set and 95%
in validation set). The AUC for alternative age-group comparisons within
our replication set is 91% for < 60 vs. age ‡ 60 and 84% for the age 60–
69 vs. age 70–79.
Key expression changes replicate when assayed by an
alternative method; TaqMan low-density array (TLDA)
analysis
Taqman low-density array quantitative real-time PCR provides a robust
independent laboratory technique to validate array results and provides
more accurate estimates of effect sizes. We validated 27 of the most
differentially expressed genes identified by microarray analysis using
TLDA quantitative real-time PCR. Of the 27 genes tested, 22 showed clear
differences in gene expression with age (see Table S3). Representative
box plots (comparing data for 49 respondents aged 30–44 years and 50
respondents aged 85–104) for one gene previously associated with aging
(CCR7) (Yung et al., 2007) and two of the top associations found in our
study, LRRN3 and LEF1, are given in Fig. 2. Of those that did not replicate,
two had no detectable expression (AKTIP and IGLL1) and three (RPS5,
E2F5 and VEGFB) showed evidence of a trend for altered expression, but
were not statistically significant. These transcripts were at the lower limit
of statistical significance following Bonferroni correction for multiple test-
ing (P = 1 · 10)5) on the microarray data, indicating that some of the
genes located at the limits of statistical significance may not represent
genuine hits.
For our top gene (LRRN3), the mean expression intensity in the young
sample (aged 30–44 years) was 1.65 (95%CI for the mean 1.36–1.94),
compared with 0.53 (CI 0.44–0.62) in the older sample (85–104 years), a
highly significant difference (P < 0.0001) (Table S3). This LRRN3 change
represented a very large reduction, i.e. the expression in the older sample
is 32% of that in the young. In our TLDA-validated genes, the expression
in the older group ranged from 32% to 175% of that in the young.
Gene set enrichment analysis (GSEA) reveals that the major
pathways affected by age in humans relate to post-
transcriptional processing of messenger RNA transcripts
We applied GSEA (Subramanian et al., 2005) to identify pathways (rather
than individual transcripts) that are associated with age. We examined
1065 predefined gene sets, grouped by (mainly Gene Ontology)
classification of molecular function or biochemical processes. Of the 1065
pathways examined, only seven pathways were significantly associated
with age, after accounting for the multiple statistical testing (FDR q-value
< 0.05) (Table 2). These were total RNA binding (nominal P-
value < 0.001), mRNA metabolic process (P < 0.001), mRNA binding
(P < 0.001), RNA splicing (P < 0.001), mRNA processing (P < 0.001),
ribonucleoprotein complex biogenesis and assembly (P < 0.001), and
chromatin assembly or disassembly (P = 0.002). Figure 3 shows the
enrichment plot for the RNA splicing pathway. Leading edge analysis
(which identifies specific genes driving observed pathway associations)
revealed that there was significant overlap between genes in these
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Fig. 2 Box plots showing gene expression changes obtained
by TaqMan low-density array (TLDA). This figure demonstrates
the difference in expression levels between young (30–
44 years; n = 49) and old (85–104 years; n = 50 years)
individuals as assessed by TLDA analysis. Gene expression
levels expressed relative to the endogenous controls are given
on the Y-axis, and the patient group (young or old) are given
on the X-axis.
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pathways, and that four pathways relate essentially to the same process;
post-transcriptional processing of messenger RNA transcripts (Fig. S2).
The remaining pathways involve genes responsible for opening or closing
the chromatin structure to allow (or disallow) transcription, and genes
involved in the production and action of ribosomes, permitting translation
of the processed messenger RNA transcript. GSEA also revealed two
biological function gene sets possibly up-regulated in older people
(extracellular region genes P = 0.004 and ion transport genes P = 0.008),
although neither were significant when accounting for multiple testing
(FDR q-value = 0.197 and q-value = 0.207, respectively).
Evidence of age-related changes in isoform ratios with
advancing age
Given the prevalence of genes involved in mRNA processing in our GSEA
results, we sought to determine whether the pattern of alternatively
expressed isoforms might therefore be disrupted with age. Of the ten
genes fulfilling our criteria for study, we found evidence of disruption to
splicing patterns in seven of these [actin-binding LIM protein 1 (ABLIM1),
STAT1, CD79a molecule, immunoglobulin-associated alpha (CD79A),
heat shock 60kDa protein 1 (HSPD1), clusterin-associated protein 1 (CLU-
AP1), lysosomal-associated membrane protein 2 (LAMP2), and SON DNA-
binding protein (SON)], and the eighth, caspase 8 (CASP8) was near sig-
nificant at P = 0.097 (Fig. S3; Table 3). The ABLIM1 gene codes for four
alternatively processed reference sequence isoforms, NM_002313.5,
NM_001003407.1, NM_001003408.1, and NM_006720.3. Comparison
of the amount of NM_006720.3 relative to the other three isoforms
reveals a progressive increase with age (correlation coefficient 0.0009;
P £ 0.0001; supplementary Fig. S3). The STAT1, CD79A, HSPD1, CLU-
AP1, LAMP2, and SON genes exhibit similar disturbances to isoform ratios
with advancing age (Table 3).
In a separate analysis, we sought to provide extra evidence for disrup-
tion of splicing with increasing age using a more accurate quantitative
technique, real-time PCR. We selected alternatively spliced genes from
the top 250 genes most associated with age, for which commercial
probes were available. Of eight genes tested in the fifty youngest and fifty
oldest individuals, we found evidence for disruption to the ratio of alter-
natively expressed isoforms in 3 (EFNA1, GPR18, and VCAN; P = 0.05,
0.05, and 0.02–0.04, respectively, depending on the comparison), with
Table 2 Gene set enrichment analysis
plots for potential age-associated gene sets,
for molecular function or biochemical
process pathways
Significance
rank with age Pathway
Source of
pathway
definition
Size (number
of genes in
pathway) NES
Nominal
P-value
FDR
q-value
1 RNA binding GO 200 )2.00092 < 0.001 0.023
2 mRNA metabolic processes GO 73 )1.92912 < 0.001 0.027
3 mRNA binding GO 19 )1.93444 < 0.001 0.029
4 RNA splicing GO 75 )1.95339 < 0.001 0.029
5 mRNA processing GO 63 )1.8974 < 0.001 0.03
6 Ribonucleoprotein complex
biogenesis ⁄ assembly
GO 68 )1.89765 < 0.001 0.036
7 Chromatin assembly or disassembly GO 20 )1.95669 0.002 0.041
8 RNA processing GO 136 )1.98935 < 0.001 0.057
9 Protein RNA complex assembly GO 56 )1.82204 0.004 0.057
10 DNA replication GO 73 )1.82487 0.002 0.063
11 DNA-dependent DNA replication GO 37 )1.77582 0.004 0.085
12 Purine metabolism KEGG 101 )1.95911 < 0.001 0.089
13 Organelle lumen GO 346 )1.66622 0.002 0.091
14 Negative regulation of programmed
cell death
GO 110 )1.71244 < 0.001 0.099
Size refers to the number of genes in the pathway. The false discovery rate (FDR) is given by the q-value and the
statistical significance by the P-value.
GO, gene ontology subset; KEGG, Kyoto encyclopedia of genes and genomes; NES, normalized enrichment score for
each gene.
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Fig. 3 Gene set enrichment analysis plot for the RNA splicing pathway. The Y-axis
gives the enrichment score for an association with age in the top panel and the
ranked list matrix in the bottom panel. The X-axis refers to the rank of each gene in
the ordered dataset. Each vertical line in the central portion of the figure refers to
one gene within the pathway. The position of each line relative to the central
dashed line indicates whether the gene is positively or negatively correlated with
age. Positive correlations with age (age-pos) locate to the left of the figure, and
negative correlations with age (age-neg) locate to the right side of the figure. The
dashed line represents the null point, where a gene demonstrating no positive or
negative correlation would appear. RLM, Ranked List Metric; ES, Enrichment score.
Gene expression changes in human aging, L. W. Harries et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
872
the 4th (BCL11B) being very near significance at P = 0.053 (Fig. S4,
Table 4).
Discussion
In this study, we present the first assessment of age-related alterations in
gene expression in a large population-based cohort. Contrary to our
expectations, we found relatively few age-associated transcripts, but
these did include several genes associated with inflammation or immune
senescence, as expected. Gene set enrichment analysis indicated that
only a very small number of molecular or biological function pathways
were robustly associated with advancing age, comprising mainly genes
involved in the processing and maturation of messenger RNA transcripts.
This finding was supported by subsequent observation of age-associated
differences in the balance of alternatively expressed isoforms, as sug-
gested by previous studies (Yannarell et al., 1977; Meshorer et al., 2002).
Our results suggest that modification of messenger RNA (mRNA) process-
ing may comprise an important feature of human aging.
Very few genes (295 of 16 571; 2% of transcripts identified) demon-
strated strong and robust associations with advancing age in our study.
Power calculations based on the method of Hsieh et al. (1998) indicate
that the relatively large sample available (n = 458 in discovery set) is suffi-
cient to detect effect sizes for transcripts statistically ‘explaining’ as little
as 5.3% of the variation in age. Thus, if we have not detected other genes
because of ‘noisy’ data, individual effect sizes for such genes are likely to
be of limited biological significance.
The transcripts with the largest effect sizes comprise a set of peripher-
ally expressed biomarkers of the aging process, some substantially stron-
ger than those currently known. Transcripts such as CCR6, CCR7, and
CD27, previously reported to be involved in immune senescence (Yung
et al., 2007), were also associated with age in our study (Fig. 1). As pre-
dicted, genes showing the largest differential in expression with age were
involved in inflammatory responses, or immune function (de Magalhaes
et al., 2009). Genes related to the human immune system, e.g. LRRN3,
CD248, LEF1, CCR6, CCR7, CD27, and LTB (lymphotoxin beta – TNF
superfamily, member 3), expressed lower levels of mRNA transcripts with
increasing age in our cohort, which is in agreement with other studies in
human peripheral lymphocytes (Hong et al., 2008). This is not unex-
pected given that our study tissue was white blood cells. Reduced expres-
sion of these genes with age implies that the mechanisms involved are
likely to mark the process of ‘immunosenescence,’ characterized by
reduced chemotactic migration of the immune mediator cells, lowered
Table 3 Analysis of the effect of age on the expression of alternatively spliced isoforms
Gene ID Isoform Mean SE Comparison Coeff CI CI P-value
ABLIM1
1 ilmn_1731610 NM_006720.3 102.29 6.21
2 ilmn_2396672 All 115.61 10.49 1 ⁄ 2 0.0009 0.0006 0.0012 < 0.0001
3 ilmn_1785424 All 209.54 53.73 1 ⁄ 3 0.0032 0.0027 0.0037 < 0.0001
STAT1
4 ilmn_1777325 NM_007315.3 317.9793 145.709
5 ilmn_1691364 NM_139266.2 715.9618 329.8048 4 ⁄ 5 )0.0026984 )0.0033706 )0.0020263 0.0033706
CD79A
6 ilmn_2410371 NM_001783.3 94.26653 4.791344
7 ilmn_1734878 All 338.5959 213.6811 6 ⁄ 7 0.0028078 0.0021338 0.0034817 0.0021338
HSPD1
8 ilmn_1784367 NM_002156.42 96.76617 3.201362
9 ilmn_1766713 All 142.1247 19.87898 8 ⁄ 9 0.0012785 0.0008516 0.0017055 0.0008516
CASP8
10 ilmn_1750596 NM_024793.1 100.70 3.63
11 ilmn_2242491 NM_024793.1 10361.48 1983.51 7 ⁄ 8 0.0000 0.0000 0.0000 < 0.0001
LAMP2
12 ilmn_1752351 NM_013995.2 238.35 52.02 12 ⁄ 14 )0.0004 )0.0011 0.0002 0.208
13 ilmn_2279961 NM_013995.2 261.87 83.04 12 ⁄ 13 )0.0016 )0.0030 )0.0002 0.027
14 ilmn_1673282 NM_002294.2 354.04 97.12
MAX
15 ilmn_1695633 NM_145116.1 93.97 4.54 15 ⁄ 16 )0.0001 )0.0003 0.0002 0.578
16 ilmn_1802457 NM_145114.1 107.29 3.99 15 ⁄ 17 )0.0002 )0.0004 0.0001 0.155
17 ilmn_1706546 NM_145113.1 108.31 5.55 16 ⁄ 17 )0.0001 )0.0004 0.0002 0.423
SON
18 ilmn_1663090 NM_032195.1 106.31 4.13
19 ilmn_2247664 NM_138927.1 200.96 45.44 18 ⁄ 19 0.0017 0.0011 0.0023 < 0.0001
WTAP
20 ilmn_1734544 NM_004906.3 238.35 52.02
21 ilmn_2279339 NM_004906.3 261.87 83.04 20 ⁄ 22 0.0003 )0.0002 0.0009 0.208
22 ilmn_1657618 NM_152857.1 354.04 97.12 21 ⁄ 22 0.0015 )0.0014 0.0044 0.305
The ratio of alternatively expressed isoforms of specific genes in relation to increasing age is given in the table above. Association with age is calculated by logistic
regression. The analysis was carried out on 689 individuals.
ABLIM1, actin-binding LIM protein 1; CAPS8, caspase 8; CI, confidence intervals; coeff, correlation coefficient; HSPD1, heat shock 60 kDa protein 1; ID, probe identity;
isoform, transcript identity; LAMP2, lysosomal-associated membrane protein 2; Mean, mean ratio; SE, standard error, comparison indicates which comparisons were
made for the analysis; STAT1, signal transducer and activator of transcription 1.
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activation and differentiation of lymphocytes and macrophages with
reduced synthesis of immunoglobulins and increased apoptosis of
immune cells. Our finding of a strong association of lower CCR7 gene
expression with advancing age validates the findings from Yung et al.
(2007).
Our findings should also be considered in the context of age-related
changes in lymphocyte composition. Some age-associated transcripts
may be expressed in different white cell subtypes; the CD28, CCR7, and
GZMH genes are differentially expressed in CD8+ CD28+ T-cells com-
pared with CD8+ CD28) T-cells, the ratio of which is known to alter with
age (Lazuardi et al., 2009). Some of the alterations in gene expression
may therefore derive from differences in the composition of the lympho-
cyte population in older people. What remains to be seen is whether any
of alterations in lymphocyte composition are themselves attributable to
the altered gene expression patterns we have demonstrated.
Several other factors have been implicated in aging or longevity, includ-
ing alterations to nutrient sensing pathways, such as insulin or TOR signal-
ing, oxidative stress ⁄DNA repair, inhibition of respiration, reproductive
system signaling, and telomere-related mechanisms (Kenyon, 2010).
Accordingly, genes representing some of these processes are evident
among the top 100 associations we have identified. These include the
PASK, FOXO1, DKC1, and MYC transcripts, involved in energy sensing,
insulin signaling, telomere maintenance, and ribosomal biogenesis,
respectively (Gu et al., 2009; Schlafli et al., 2009; Dai et al., 2010; Smith
et al., 2010).
The association of individual gene transcripts with age does not
account for correlations between markers. We developed a bi-class discri-
minant model that identified a set of six transcripts within the top 25
strongest associations that form a potential predictive signature of chro-
nological aging (Table S2; Fig. S1). This model was exceptionally good at
classifying young and old [the area under ROC curve was 96% in our dis-
covery set, and this was only slightly diminished (95%) in the independent
replication set]. The six genes in the predictive group comprise genes
involved in immunity or inflammation (LRRN3, CD27, CCR6) but also
include some that are involved in the maintenance or development of
muscle tissue (VAMP5; myobrevin) or in vascularization (CD248, endosia-
lin). Future versions of this discriminant model might attempt to disentan-
gle ‘aging’ from age-related disease effects: however, doing so is
conceptually and practically difficult, but the relative robustness of the
model for different age-group comparisons suggests that the transcript
set is not merely distinguishing disease-free, from diseased, individuals.
Gene set enrichment analysis revealed a striking restriction in the num-
ber of pathways that were associated with age in our dataset; only seven
of 1065 molecular or biological function pathways are robustly associated
with age. Four of these pathways identified are involved in mRNA pro-
cessing (namely mRNA binding, mRNA processing, mRNA processing re-
actome, and RNA splicing). Three of the age-associated pathways we
identified (RNA binding, RNA splicing, and ribosome biogenesis and
assembly) were also noted in previous GSEA analyses in mice (Southworth
et al., 2009). Differences between our results and the studies may arise
from differences between species in the aging process, or from differ-
ences in the tissue specificity of changes.
RNA processing is the mechanism by which the initial RNA products
transcribed from genes are prepared for eventual translation. This
includes removal of introns and addition of the poly-A tail and 5¢ Cap
structures (Keene, 2010). These processes occur simultaneously and
Table 4 Genes showing disruption to the balance of alternatively spliced isoforms by real-time PCR
Gene ID Isoform Mean SE Comparison Coeff CI CI P-value
BCL11B
1 hs01102259_m1 NM_138576.2 1.058325 0.349844
2 hs01112109_m1 NM_022898.1 1.062152 0.36903 1 over 2 0.00125 )0.0000175 0.0025182 0.053
EFNA1
3 hs00358887_m1 NM_004428.2 1.376142 1.084887
4 hs01020895_m1 NM_182685.1 1.315693 1.144735 3 over 4 )0.00394 )0.0078545 )0.0000253 0.049
GPR18
5 hs00245542_m1 NM_001098200.1 1.070176 0.407375
6 hs01649814_m1 NM_005292.3 1.081336 0.446335 5 over 6 0.00189 3.60E-06 0.0037757 0.05
VCAN
7 hs01007937_m1 NM_001164097.1 1.098376 0.559999
8 hs01007941_m1 NM_001126336.2 1.086235 0.457961 7 over 8 0.002647 0.0001322 0.0051619 0.039
9 hs01007943_m1 NM_001164098.1 1.23125 0.845863 9 over 7 )0.01048 )0.0193924 )0.0015691 0.022
10 hs01007944_m1 NM_004385.4 1.210006 0.92149 9 over 10 )0.00778 )0.0154129 )0.0001444 0.046
ANXA7
11 hs00244504_m1 NM_004034.2 1.066305 0.388382 12 over 11
12 hs00559416_m1 NM_001156.3 1.929157 8.420153 11 over 12 )0.00219 )0.0057466 0.0013578 0.223
CXCR5
13 hs00540527_s1 NM_001716.3 1.116763 0.540786 14 over 13
14 hs00540548_s1 NM_032966.1 1.100177 0.497535 13 over 14 )0.0011 )0.0026285 0.0004256 0.156
IGL6ST
15 hs01006741_m1 NM_002184.3 1.068342 0.397245 16 over 15
16 hs01006742_m1 NM_175767.2 1.898088 5.478007 15 over 16 0.004691 )0.0045713 0.0139524 0.317
PUM1
17 hs00982771_m1 NM_001020658.1 1.031583 0.253846
18 hs00985111_m1 NM_014676.2 1.091318 0.995023 17 over 18 0.001596 )0.0003754 0.0035682 0.111
The ratio of alternatively expressed isoforms of specific genes as determined by real-time PCR is correlated with age in the table above. Association with age is
calculated by logistic regression. The analysis was carried out on 100 individuals.
CI, confidence intervals; coeff, correlation coefficient; ID, probe identity; isoform, transcript identity; Mean, mean ratio; SE, standard error, comparison indicates which
comparisons were made for the analysis.
Gene expression changes in human aging, L. W. Harries et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
874
ensure diversity of the mRNA transcriptome and determine stability and
half-life of the mRNA transcripts (Fong & Bentley, 2001). In our GSEA
analysis, transcripts responsible for all aspects of mRNA processing were
present in the core-enriched fraction of the pathway (Table S4 online),
with a surprising amount of overlap between the groups (Fig. S2). The
remaining pathways relate to the accessibility of the chromatin to tran-
scription factors (chromatin assembly and disassembly) and to the pro-
cesses that surround the translation of the mRNA transcripts (RNA-
binding and ribonucleoprotein complex biogenesis and assembly), which
is in keeping with previous observations of a reduction in rates of protein
synthesis with age in humans and animal species (Ballard & Read, 1985;
Kennedy & Kaeberlein, 2009).
Our observation that disruption to the proteins involved in mRNA pro-
cessing appears to occur without widespread alterations in gene expres-
sion levels may indicate that while aged leukocytes in-vivo may be
expressing most genes at comparable levels to those found in younger
cells, there may be differences in the relative balance of splice products
produced or increases in the occurrence of aberrantly spliced transcripts.
In seven of ten alternatively spliced genes we studied, we found disrup-
tions to the patterns of isoform expression with increasing age, and a
near-significant result in one further case (Table 3). We also noted varia-
tion in splicing patterns with age by real-time PCR, finding alteration to
the balance of alternatively expressed isoforms in 3 of 8 (38%) alterna-
tively spliced genes, with the 4th very near significance. Our observation
of very modest effects even in a very limited cohort of 100 people (7–
37% alteration in the ratio of isoforms) suggests that the true level of
splicing disruption may be higher than we report and warrants a more
detailed, targeted study.
Whether or not the processing of a particular transcript is disrupted will
depend on many factors, not least how many different sequence ele-
ments are necessary to ensure the usage of a particular splice junction.
Presumably, highly regulated transcripts with weaker splice sites that are
very dependent on additional sequence factors (such as exon splicing
enhancers (Cartegni et al., 2002)) may be more susceptible to age-accu-
mulated DNA and RNA damage and thus more likely to show disruption
of splicing and other related processes with age. Interestingly, two of the
most deregulated splicing proteins in our microarray data, SRFR6 (SRp55)
and SRFS1 (ASF ⁄ SF2) (P = 1.3 · 10)6 and 0.0001, respectively), were
members of the SRFS (Splicing Factor, Arginine ⁄ Serine-Rich) family of
splicing factors, which are key players in maintaining the plasticitiy of the
transcriptome by regulation of alternative splicing (Valcarcel & Green,
1996). This is particularly interesting because these proteins are key
ligands for the exon splicing enhancer (ESE) motifs that regulate splice site
choice in development and differentiation (Cartegni et al., 2002). Their
deregulated expression during the aging process may therefore manifest
as a reduction in the adaptive capacity of the transcriptome.
Disruption to the mRNA processing machinery may also lead to an
increase in the occurrence of unusual or aberrant splicing products, which
of course would not be present on the microarray chip. This would not be
an unexpected finding in an aging organism, given that they may arise
from mutations in the DNA sequence elements that control splice site
usage, or from alterations in the RNA transcript itself, which is very sus-
ceptible to damage by oxidative and other insult (Kong & Lin, 2010).
Some of the proteosomal components that intercept and neutralize aber-
rant proteins produced from such transcripts were up-regulated in our
data (PMSB9; FDR q-value = 0.008, P = 6 · 10)5, PMSB10; q = 0.005,
P = 0.0008).
There is a growing body of evidence that results from peripheral blood
white cells are also relevant to less accessible tissues (Tang et al., 2003;
Twine et al., 2003; Achiron et al., 2004). In some reports, the majority of
changes appeared to be in genes with little tissue-specific regulation, sug-
gesting that most of the transcriptomic alterations with age might be
generalized (Rodwell et al., 2004; de Magalhaes et al., 2009). This is sup-
ported by other evidence, where age-related expression differences were
compared in brain, kidney, and muscle, in a population of 81 human sub-
jects, and found to be conserved in each of these tissues (Zahn et al.,
2007). The age-related transcriptomic signature is also relatively stable; of
the 50 top associations reported by Hong et al., (2008), 32 of the 42 rep-
resented in our data also showed age-related differences, at least at
P £ 0.05 (data available from authors), despite the differences expected
comparing our in-vivo leukocyte mRNA to mRNA from stored isolated
lymphocytes. Lymphocytes are also the most appropriate tissue for the
study of immune senescence, which is key to many chronic disease pro-
cesses, including inflammation, and autoimmune alterations with age
(Desai et al., 2010).
Possible limitations of our study analysis include the deliberate absence
of accounting for specific disease. This is because an increased suscepti-
bility to disease is intrinsic to any definition of aging, and thus accounting
for disease would risk controlling out the associations of interest (and also
poses major practical difficulties with undiagnosed disease being com-
mon at older ages). Similarly, our study does not account for variation in
the transcriptome of different blood cell subtypes. However, as noted
above, our results are consistent with those from isolated lymphocytes
(Hong et al., 2008), and our approach avoids disruption to in-vivo expres-
sion patterns.
In conclusion, we present the first genome-wide assessment of age-
related in-vivo leukocyte gene expression profiles in a large population-
based study. As aging is associated with random damage to DNA (Gens-
ler & Bernstein, 1981), we tested the hypothesis that this would result in
widespread deregulation of gene expression. Instead, we found that
human aging is associated with a small number of focused changes,
mainly in individual genes associated with immune cell function. The
major pathways associated with older age in humans were mainly
involved with the processing of the primary RNA transcripts into mature
mRNAs, an observation supported by our finding of age-related changes
in the relative expression of alternatively expressed isoforms of example
loci. We suggest that disruption to messenger RNA processing may com-
prise an important feature of aging in the human population.
Experimental procedures
Ethics statement
Ethical permission was granted by the Instituto Nazionale Riposo e Cura
Anziani institutional review board in Italy. Participants gave informed con-
sent to participate.
Cohort details
The InCHIANTI study (Ferrucci et al., 2000) is a population-based, pro-
spective epidemiological study of factors affecting aging, in the Chianti
area (Tuscany) of Italy. The participants were originally enrolled in 1998–
2000 and were interviewed and examined every 3 years. The recent 9-
year follow-up examination involved 733 participants. Characteristics of
the study cohort are given in Table 5.
RNA collection and extraction
Peripheral blood specimens preserving in-vivo RNA expression were col-
lected at the 9-year follow-up (2008 ⁄ 9), using the PAXgene technology
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to preserve levels of mRNA transcripts as they were at the point of collec-
tion (Debey-Pascher et al., 2009). RNA was extracted from peripheral
blood samples using the PAXgene Blood mRNA kit (Qiagen, Crawley, UK)
according to the manufacturer’s instructions.
Whole transcriptome scan
Whole genome expression profiling of the samples was conducted using
the Illumina Human HT-12 microarray (Illumina, San Diego, California,
USA) as previously described (Zeller et al., 2010). Preprocessing of micro-
array data is described in the Data S1.
Statistical analysis
Our dataset was subdivided on the basis of hybridization batch: a discov-
ery dataset containing approximately two-thirds of the full sample
(n = 458 individuals), and an independent replication set (n = 240 indi-
viduals). This is a form of test-set cross-validation, a common and well-
established approach when assessing performance of classification mod-
els (Lubomirski et al., 2007).
We calculated median centered gene expression levels on the log2 scale
to ensure maximum overlap of profiles without altering their variance, in
line with methodology used in previous studies (Idaghdour et al., 2010).
The relationship between gene expression and chronological age was
tested using a linear regression model with (log-transformed) gene
expression level as the dependent variable, chronological age (recorded
at RNA extraction) as an explanatory variable, and with adjustment for
potential confounders. Separate regression models were fitted for each
of the full set of 16 571 probes which passed QC in the discovery dataset.
We used the FDR to account for multiple testing, applying an FDR cut off
of q £ 0.001 to select probes expressing differentially with age. Tran-
scripts selected at the screening stage in the discovery set were tested for
association with age in the replication dataset using the same model
specification. The development of a bi-class discriminant model to iden-
tify the transcripts explaining the majority of the association with age is
described in the Data S1.
All our analyses were adjusted for the following potential confounding
factors on gene expression: gender; lifetime pack years smoked (in five
categories: none, < 20 years, 20–39 years, 40 plus years, and missing);
waist circumference (as a continuous trait); highest level of education
attained (in five categories: none, elementary, secondary, high school,
and university ⁄ professional); and study site [individuals were drawn from
a rural village (Greve) and an urban population (Bagno a Ripoli)]. We also
controlled for potential hybridization and ⁄ or amplification batch effects
in all our analyses (Table S5).
TaqMan low-density array (TLDA) validation of microarray
results
A subset of the cohort comprising the oldest men and women
(85–104 years, n = 50) was compared with one comprising the youn-
gest men and women (30–44 years, n = 49) in this analysis. Total RNA
(100 ng) was reversed transcribed in 20-lL reactions using the Super-
script III VILO kit (Invitrogen, Paisley, UK), according to the manufac-
turer’s instructions. RNA samples were then used for TLDA analysis. A
list of target genes is given in Table S6. Each 32-gene set included four
endogenous control genes which had been empirically validated as
being unaffected by age on the basis of the microarray results; 18S,
GUSB, PPIA, and IDH3B. Reaction conditions are described in the
Data S1.
Table 5 Characteristics of the discovery
and replication samples. Clinical
characteristics and demographics of the
study cohort are given
Discovery sample Replication sample Pooled sample
n % n % n %
Age (quartiles)
30–68 years 121 26.42 59 24.58 180 25.79
69–78 years 141 30.79 72 30 213 30.52
79–82 years 91 19.87 43 17.92 134 19.2
83–104 years 105 22.93 66 27.5 171 24.5
Gender
Men 211 46.07 102 42.5 313 44.84
Women 247 53.93 138 57.5 385 55.16
Site
Greve 188 41.05 154 64.17 342 49
Bagno a Ripoli 270 58.95 86 35.83 356 51
Education
Nothing 65 14.19 29 12.08 94 13.47
Elementary 199 43.45 123 51.25 322 46.13
Secondary 55 12.01 38 15.83 93 13.32
High school 62 13.54 25 10.42 87 12.46
University ⁄ professional 77 16.81 25 10.42 102 14.61
Pack years smoked (lifetime)
None 249 54.37 130 54.17 379 54.30
< 20 97 21.18 56 23.33 153 21.92
20–39 71 15.50 30 12.50 101 14.47
40+ 35 7.64 20 8.33 55 7.88
Missing 6 1.31 4 1.67 10 1.43
Waist circumference (cm)
Mean (SD) 458 95.6 (12.4) 240 94.8 (11.5) 698 95.3 (12.1)
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Pathway analysis (GSEA)
Gene set enrichment analysis was performed to assess pathways or
predefined gene sets associated with chronological age according to
the method of Subramanian et al. (2005). ‘Enrichment statistic’ and
‘Metric for ranking gene’ parameters were configured to ‘Weighted’
and ‘Pearson,’ respectively. One thousand random permutations of
the phenotype label were used to calculate the empirical P-values of
each pathway. The gene sets with a nominal of P-value < 0.01 and
FDR of £ 25% were considered as potential associated gene sets as
previously described (Subramanian et al., 2005). Gene symbols and
the Illumina annotation file were used to collapse 16 571 probes to
12 357 genes by taking the median intensity of probes representing
each gene.
Molecular or biological function pathways and Gene Ontology (GO)
gene sets were selected from the molecular signature database (MSigDB)
(http://www.broadinstitute.org/gsea/msigdb/index.jsp). After filtering
gene sets to those with a minimum of 15 and a maximum of 500 gene
set size, 294, 439, 209, and 123 gene sets from the Canonical pathways,
Biological Process Ontology gene sets, Molecular Function Ontology gene
sets, and Cellular Components Ontology gene sets were used in the anal-
ysis, respectively.
Examination of age-related changes in microarray isoform
ratios with advancing age
We examined the relative balance of alternatively expressed isoforms of
selected genes for evidence of disruption to splicing patterns. We first
examined the top 50 genes robustly associated with age (Table S1)
identified as candidates for study, but only four of them, ABLIM1,
CD79A, STAT1 and HSPD1, showed evidence both of alternative splic-
ing, and expression identified by suitable probes within the expression
data available to us. We then selected further genes for study based on
the following criteria: the presence of > 5 alternative probes for the
same gene, and the presence of > 2 reference isoforms for the gene.
The probe sequences were then mapped back onto the specific
transcript sequences to determine which probe signals to use for analy-
sis. By these methods, we identified ten genes for study: ABLIM1,
CD79A, STAT1, HSPD1, CASP8, CLUAP1, LAMP2, MAX, SON, and
WTAP. We then carried out a logistic regression of the ratio of signal
deriving from isoform-specific probes according to age. Data were
adjusted for gender.
TaqMan low-density array (TLDA) assessment of disruption
to mRNA splicing
A subset of the cohort comprising the oldest men and women (85–
104 years, n = 50) was compared with one comprising the youngest
men and women (30–44 years, n = 50) in this analysis. Total RNA
(100 ng) was reversed transcribed in 20-lL reactions using the Super-
script III VILO kit (Invitrogen), according to the manufacturer’s instruc-
tions. RNA samples were then used for TLDA analysis for transcripts of
the ANXA7, BCL11B, CXCR5, EFNA1, GPR18, IL6ST, PUM1, and VCAN
genes, which were selected on the basis that they were alternatively
expressed isoforms of genes in the top 250 associations with age which
produced a minimum of two isoforms. Endogenous control genes were
IDH3B and GUSB, which were identified as the most stable controls by
the GeNORM function of the STATMINER TLDA analysis software (Integro-
mics, Granada, Spain). Reaction conditions are described in the
Data S1.
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